IGC Pharma, Inc. (IGC): Capital Expenditures
Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$112.0K
Year ended 2025-03-31
$82.0K
Trailing 12 months to 2025-09-30
-22.0%
3-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-03-31 | $112.0K | -18.8% | 2025-06-27, From 2024-04-01 |
| 2024-03-31 | $138.0K | -55.5% | 2025-06-27, From 2023-04-01 |
| 2023-03-31 | $310.0K | +31.4% | 2024-06-24, From 2022-04-01 |
| 2022-03-31 | $236.0K | n/c | 2023-07-07, From 2021-04-01 |
| 2021-03-31 | $1.47M | -66.5% | 2022-06-23, From 2020-04-01 |
| 2020-03-31 | $4.39M | n/m | 2021-06-14, From 2019-04-01 |
| 2019-03-31 | $15.0K | -89.0% | 2020-07-13, From 2018-04-01 |
| 2018-03-31 | $136.0K | -6.6% | 2019-06-14, From 2017-04-01 |
| 2017-03-31 | $145.7K | +19.2% | 2018-06-21, From 2016-04-01 |
| 2016-03-31 | $122.2K | +59.7% | 2017-07-14, From 2015-04-01 |
| 2015-03-31 | $76.5K | +801.9% | 2016-07-14, From 2014-04-01 |
| 2014-03-31 | $8.5K | -97.4% | 2015-07-14, From 2013-04-01 |
| 2013-03-31 | $326.1K | n/m | 2014-07-15, From 2012-04-01 |
| 2012-03-31 | $5.5K | -98.1% | 2014-07-15, From 2011-04-01 |
| 2011-03-31 | $285.4K | n/a | 2012-07-16, From 2010-04-01 |